EUVIMEDEUVIMED entdecken
Übersichtsarbeit

KRAS G12C-mutant non-small cell lung cancer: A practical guide for clinicians

Jordi Remon, Giulia La-Cava, Maxime Borgeaud, Stephanie P L Saw, Lizza El Hendriks, Biagio Ricciuti

Cancer Treatment Reviews · 2026-06 · 147 · 103144

DOI: 10.1016/j.ctrv.2026.103144 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancer Treatment Reviews, 2026-06. Verfasst von Jordi Remon und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Thoracic Group, Gustave Roussy, Villejuif, France; Paris-Saclay University, Paris, France. Electronic address: JORDI.…. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Proto-Oncogene Proteins p21(ras). Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 85 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsProto-Oncogene Proteins p21(ras)HumansMutation

Stichwörter der Autor:innen

AdagrasibKRAS G12C–mutantNon-small cell lung cancerPan-RAS inhibitorsSotorasib

Substanzen

Proto-Oncogene Proteins p21(ras)KRAS protein, human

Autor:innen und Institutionen

  • Department of Medical Oncology, Thoracic Group, Gustave Roussy, Villejuif, France; Paris-Saclay University, Paris, France. Electronic address: JORDI.REMON-MASIP@gustaveroussy.fr.
  • Department of Medical Oncology, Thoracic Group, Gustave Roussy, Villejuif, France; Paris-Saclay University, Paris, France; Department of Medicine and Surgery, University Campus Bio-Medico of Rome, Rome, Italy.
  • Department of Medical Oncology, Thoracic Group, Gustave Roussy, Villejuif, France; Paris-Saclay University, Paris, France; Oncology Department, University Hospital Geneva, Geneva, Switzerland.
  • Division of Medical Oncology, National Cancer Centre Singapore, Singapore.
  • Department of Pulmonary Diseases, Maastricht University Medical Centre (+), GROW Research Institute for Oncology and Reproduction, Maastricht, the Netherlands.
  • Lowe Center of Thoracic Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, United States.

Zitieren

APA

Remon, J., La-Cava, G., Borgeaud, M., Saw, S. P. L., Hendriks, L. E., & Ricciuti, B. (2026). KRAS G12C-mutant non-small cell lung cancer: A practical guide for clinicians. Cancer Treatment Reviews, 147, 103144. https://doi.org/10.1016/j.ctrv.2026.103144

Vancouver

Remon J, La-Cava G, Borgeaud M, Saw SPL, Hendriks LE, Ricciuti B. KRAS G12C-mutant non-small cell lung cancer: A practical guide for clinicians. Cancer Treatment Reviews. 2026;147:103144. doi:10.1016/j.ctrv.2026.103144

BibTeX
@article{Remon2026,
  author = {Remon, Jordi and La-Cava, Giulia and Borgeaud, Maxime and Saw, Stephanie P L and Hendriks, Lizza El and Ricciuti, Biagio},
  title = {KRAS G12C-mutant non-small cell lung cancer: A practical guide for clinicians},
  journal = {Cancer Treatment Reviews},
  year = {2026},
  volume = {147},
  pages = {103144},
  doi = {10.1016/j.ctrv.2026.103144}
}
Kostenlos starten →